The linkage between RGS19, cAMP/CREB pathway and Nm23-H1/2 expression described herein may provide clues to the in vivo effectiveness of cAMP-modifying agents that suppress cancer cell migration [44, 45]. The gene discussed is CREB1; the disease is cancer.